Contract award · 25 Mar 2026

Provision of Assay Kits for SCID & SMA In-Service Evaluations - EONIS-Q Revvity

NHS England awarded “Provision of Assay Kits for SCID & SMA In-Service Evaluations - EONIS-Q Revvity” to Revvity (UK) Limited for £4.07m on 25 Mar 2026.

Medical equipment & pharmaceuticalsLondon

BuyerNHS England
Value £4.07m

Competition with a shortlist

Competitive procedure with a selection stage: suppliers were shortlisted before being invited to bid.

Key facts

Buyer
NHS England · Body governed by public law
Value
£4,074,117
Procedure
Call-off from a framework agreement
Sector
Medical equipment & pharmaceuticals · Medical equipments (CPV 33100000)
Region
London
Timeline
  1. Contract date25 Mar 2026
  2. Published12 Mar 2026Published 13 days before the contract date

Description

EONIS-Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 4 Screening laboratories, with the addition of the ISE for Spinal Muscular Atrophy (SMA).

About the supplier

More from NHS England

All contracts

More won by Revvity (UK) Limited

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview